Agreement further expands Angelini Pharma’s strong portfolio and deep therapeutic expertise in brain health, following a series of strategic partnerships in the space, including in orphan and rare ...

Rome, Italy, 11 th June 2025 – Angelini Ventures, the corporate venture firm of Angelini Industries focused on investing in companies developing innovative solutions in BioTech and Digital Health, ...

Rome-based Angelini Pharma has inked a multiyear deal with Massachusetts biotech Quiver Bioscience to advance novel therapies for genetic epilepsies, which could garner up to $120 million in milestone ...

ROME, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Angelini Pharma, part of the privately owned Angelini Industries, and Sovargen, a South-Korean biotechnology company, announced today that they signed an ...